MedTrace Logo

A Pilot Clinical Study to Evaluate the Feasibility of Using the SPC Test

NCT06521528 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 237

Last updated 2024-07-29

No results posted yet for this study

Summary

Precision medicine approaches emphasize the importance of reliable prognostic tools for guiding individualized therapy decisions. In this study, we evaluated the clinical feasibility of the Single Patient Classifier (SPC) test, a new clinical-grade prognostic assay, in stage II-III gastric cancer patients.

Conditions

Interventions

DEVICE

nProfiler I Stomach Cancer Assay Kit

nProfiler I Stomach Cancer Assay Kit (Novomics Co., Korea)

Sponsors & Collaborators

  • Novomics. Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Young-Woo Kim, MD., Ph.D · National Cancer Center

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2020-08-30
Completion
2025-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06521528 on ClinicalTrials.gov